首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
ISSN：1540-658X

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

ASSAY DRUG DEV TECHN
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：>12周，或约稿
新锐分区：医学4区
年发文量：29
影响因子：1.7
JCR分区：Q3

基本信息

分析和药物开发技术提供了新的技术和强大的工具，使早期筛选的关键进展。这项发表在杂志上的研究为药物的发现和开发提供了重要的治疗方法和平台。这本着名的同行评审期刊以原创论文为特色，以应用为导向的技术评论，关于新的和新兴的研究领域的主题问题，以及方法学和技术应用的报告。分析和药物开发技术覆盖范围包括：-分析设计，靶点开发和高通量技术-通过临床前候选人选择实现领先优化和药物化学-实验室自动化，样品管理，生物信息学，数据挖掘，虚拟筛选和数据分析-为基因家族，遗传和传染性疾病配置的分析方法-使模式生物适应药物发现的分析和策略-使用干细胞作为疾病模型-将表型输出转化为靶点识别-分析和筛选伪像的技术基础的探索和机制研究
1540-658XSCIE/Scopus收录
1.7
点击查看最新影响趋势>
1.8
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：BIOCHEMICAL RESEARCH METHODS
SCIE
Q4
66/86
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
256/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：BIOCHEMICAL RESEARCH METHODS
SCIE
Q4
72/86
学科：PHARMACOLOGY & PHARMACY
SCIE
Q4
266/353
52
29
点击查看年发文量趋势图>
6%较易>12周，或约稿-医学-生化研究方法
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
62.07%2.25%-
CiteScore：3.30
SJR：0.308
SNIP：0.544
学科类别分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Drug Discovery
Q3
103 / 156
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Molecular Medicine
Q3
131 / 177

期刊高被引文献

Coadministration of Polypeptide-k and Curcumin Through Solid Self-Nanoemulsifying Drug Delivery System for Better Therapeutic Effect Against Diabetes Mellitus: Formulation, Optimization, Biopharmaceutical Characterization, and Pharmacodynamic Assessment.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.902
High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.896
High-Content and High-Throughput In Vivo Drug Screening Platforms Using Microfluidics.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.908
Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and In Vitro Characterization.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.920
Electrophysiological and Pharmacological Characterization of Human Inwardly Rectifying Kir2.1 Channels on an Automated Patch-Clamp Platform
来源期刊：Assay and Drug Development TechnologiesDOI：10.1089/adt.2018.882
High-Content Screening Identifies New Inhibitors of Connexin 43 Gap Junctions.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.927
High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral Drugs.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.881
The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.923
Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.898
Molecular Docking and In Silico Cogitation Validate Mefenamic Acid Prodrugs as Human Cyclooxygenase-2 Inhibitor.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.943
Macrophage Cytological Profiling and Anti-Inflammatory Drug Discovery.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.894
In Vitro Evaluation of Small Molecule Delivery into Articular Cartilage: Effect of Synovial Clearance and Compressive Load.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.907
Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.895
Automated Machine Learning Diagnostic Support System as a Computational Biomarker for Detecting Drug-Induced Liver Injury Patterns in Whole Slide Liver Pathology Images.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.919
Human-Derived Brain Models: Windows Into Neuropsychiatric Disorders and Drug Therapies.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.922
Quality by Design-Based Crystallization of Curcumin Using Liquid Antisolvent Precipitation: Micromeritic, Biopharmaceutical, and Stability Aspects.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.913
Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.870
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
来源期刊：Assay and Drug Development TechnologiesDOI：10.1089/adt.2019.950
Fenugreek Leaf Extract and Its Gel Formulation Show Activity Against Malassezia furfur.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.918
Developing a High-Throughput Assay for the Integral Membrane Glycerol 3-Phosphate Acyltransferase.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.935
A Nonradioactive High-Throughput Screening-Compatible Cell-Based Assay to Identify Inhibitors of the Monocarboxylate Transporter Protein 1.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.936
Drug Repurposing Approach for Developing Novel Therapy Against Mupirocin-Resistant Staphylococcus aureus.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.944
Analysis and Quantification of Oxidized Low-Density Lipoprotein-Induced Lipid Droplets in Macrophages Through High-Content Screening: Application for Antiatherogenic Drugs Discovery.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.930
Technology for Discovery of Antifibrotic Drugs: Phenotypic Screening for LARP6 Inhibitors Using Inverted Yeast Three Hybrid System.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.904
Development of Nanoemulsion Preconcentrate of Capsanthin with Improved Chemical Stability.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.916
High-Throughput Three-Dimensional Hydrogel Cell Encapsulation Assay for Measuring Matrix Metalloproteinase Activity.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.877
Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.942
Zidovudine and Lamivudine as Potential Agents to Combat HIV-Associated Neurocognitive Disorder.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.941
Protective and Modulatory Effects of Trapa bispinosa and Trigonella foenum-graecum on Neuroblastoma Cells Through Neuronal Nitric Oxide Synthase.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.912
In Silico Screening to Identify Inhibitors of Growth Factor Receptor 2–Focal Adhesion Kinase Interaction for Therapeutic Treatment of Pathological Cardiac Hypertrophy
来源期刊：Assay and Drug Development TechnologiesDOI：10.1089/ADT.2018.887
Neural Progenitor Cell Derivation Methodologies for Drug Discovery Applications.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.921
The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.914
Single-Molecule Characterization of Drug Delivery Systems.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.903
Possible Antidiabetic and Antioxidative Activity of Hydro-Methanolic Extract of Musa balbisiana (Colla) Flower in Streptozotocin-Induced Diabetic Male Albino Wistar Strain Rat: A Genomic Approach.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2018.889
Literature Search and Review.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.29087.lit
Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.
来源期刊：Assay and drug development technologiesDOI：10.1089/adt.2019.940

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
否